期刊文献+

重组MMP-2干预后人肾系膜细胞对单核细胞趋化及黏附的影响 被引量:1

Effects of human renal mesangial cells on chemotaxis and adhesion of monocytes after intervened by recombinant MMP-2
原文传递
导出
摘要 目的观察重组基质金属蛋白酶2(MMP-2)干预后人肾系膜细胞(HRMCs)对单核细胞U937趋化及黏附的影响。方法分别用不同浓度(0、0.625、1.25、2.5、5ng/ml)重组MMP-2干预体外培养的HRMCs,6h后行U937趋化及黏附实验。用不同浓度(0、0.5、1、2、3、4、5ng/ml)重组MMP-2干预HRMCs,6h后采用RT-PCR、Western blot检测HRMCs的fractalkine(Fkn)mRNA及其蛋白表达。结果 0、0.625、1.25、2.5、5ng/ml重组MMP-2干预后,每高倍视野的趋化U937细胞数分别为6.55±0.51、14.21±0.95、23.54±1.56、34.48±1.47、48.52±3.55,黏附U937细胞数分别为4.67±0.88、3.33±0.33、2.67±0.56、2.00±0.34、1.33±0.45。Fkn mRNA及蛋白表达水平随MMP-2干预浓度的增加而增加。结论重组MMP-2干预后,HRMCs对U937的趋化作用增强,黏附作用减弱。 Objective To investigate the effects of human renal mesangial cells(HRMCs) on chemotaxis and adhesion of U937 monocytes after intervened by recombinant matrix metalloproteinase-2(MMP-2). Methods Chemotaxis test and adhesion test of U937 monocytes were performed after HRMCs were intervened by different concentrations(0,0. 625,1.25,2. 5,5 ng/ml) of recombinant MMP-2 in vitro for 6 hours. The expressions of fractalkine(Fkn) mRNA and protein in HRMCs were detected by RT-PCR and Western blot, respectively, after HRMCs were intervened by different concentrations(0,0. 5,1,2,3,4,5 ng/ml) of recombinant MMP-2 in vitro for 6 hours. Results After intervened by different concentrations(0,0. 625,1.25,2. 5,5 ng/ml) of recombinant MMP-2, the counts of chemotactic U937 monocytes in a high power field were 6.55 ~ 0.51,14. 21 ~ 0. 95,23. 54± 1.56,34. 48+1.47,48. 52±3.55, and those of adherent U937 monocytes were 4. 67±0. 88,3. 33±0. 33,2.67±0. 56,2.00±0. 34,1.33±0. 45, respectively. The expressions of Fkn mRNA and protein in HRMCs were increased along with increasing of recombinant MMP-2 concentration. Conclusion HRMCs can increase chemotaxis and decrease adhesion of U937 monocytes after intervened by recombinant MMP-2.
出处 《江苏医药》 CAS CSCD 北大核心 2012年第21期2514-2517,共4页 Jiangsu Medical Journal
关键词 基质金属蛋白酶2 Fractalkine人肾系膜细胞 MMP-2 Fractalkine Human renal mesangial cell
  • 相关文献

参考文献11

  • 1Van Lint P, Libert C. Chemokine and eytokine processing bymatrix metalloproteinases and its effect on leukocyte migration and inflammation[J]. J Leukoc Biol, 2007, 82 (6) 1375-1381.
  • 2Elkington PT, O'Kane CM, Friedland JS. The paradox of matrix metalloproteinases in infectious disease[J]. Clin Exp Immunol, 2005,142(1) : 12-20.
  • 3杨益宁,孙子林,杨涛,马婵娟,马里,刘乃丰.糖基化终产物对人肾系膜细胞MMP-2表达的影响[J].东南大学学报(医学版),2006,25(5):349-352. 被引量:7
  • 4RA, Overall CM. Proteomics discovery of metalloproteinase substrates in the cellular context by iTRAQ labeling reveals a diverse MMP-2 substrate degradome [J]. Mol Cell Proteomics, 2007 ,6(4) :611-623.
  • 5Chapman GA, Moores KE, Gohil J, et al. The role of fractalkine in the recruitment of monocytes to the endothelium[J]. Eur J Pharmacol, 2000,392(3) : 189-195.
  • 6Haskell CA, Cleary MD, Charo IF. Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduetion. Rapid flow arrest of CX3CRl-expressing cells is independent of C-protein activation [J]. J Biol Chem, 1999, 274 (15) : 10053-10058.
  • 7Imai T, Hieshima K, Haskell C, et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion [J]. Cell, 1997,91(4) :521-530.
  • 8Fong AM, Robinson LA, Steeber DA, et al. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow[J]. J Exp Med, 1998,188(8) : 1413-1419.
  • 9Goda S, Imai T, Yoshie O, et al. CX3C-chemokine, fraetalkine enhanced adhesion of THP-1 cells to endothelial cells through integr[n-dependent and independent mechanisms [J]. J Immunol, 2000,164 (8) : 4313-4320.
  • 10Umehara H, Bloom E, Okazaki T, et al. Fractalkine and vascular injury[J]. Trends Immunol, 2001,22 (11) : 602-607.

二级参考文献8

  • 1赵志涛,于晓艳,李才,苗春生,崔伦文.糖基化终末产物对大鼠肾系膜细胞基质金属蛋白酶2活性和表达的影响[J].吉林大学学报(医学版),2004,30(6):843-845. 被引量:9
  • 2顾秀锋,陆静,刘乃丰.氨基胍与葛根素对糖尿病大鼠肾脏结缔组织生长因子表达的影响[J].东南大学学报(医学版),2005,24(1):13-16. 被引量:10
  • 3DEROSA G,AVANZINI M A,GEROLDI D,et al.Matrix metalloproteinase-2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes[J].Diabetes Care,2004,27 (1):273-274.
  • 4McLENNAN S,FISHER E,MARTELL S Y,et al.Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells:possible role in diabetic nephropathy[J].Kideny Int,2000,58 (suppl 77):S81-87.
  • 5SINGH R,SONG R H,ALAVI N,et al.High glucose decrease matrix metallorpoteinase-2 activity in rat mesangia cells via transforming growth factor-beta 1[J].Exp Nephrol,2001,9:249 -257.
  • 6BARICOS W H,CORTEZ S L,DEBOISBLANC M,et al.Transforming growth factor-beta is a potent inhibitor of extracellular matrix degradation cultured human mesangial cells[J].J Am Soc Nephrol,1999,10:795.
  • 7ZIYADEH F N,HAND C.Involvement of transforming growth factor-beta and its receptors in the pathogenesis of diabetic nephrology[J].Kidney Int Suppl,1997,60:S7-11.
  • 8McLENNAN S V,WANGX Y,MORENO V,et al.Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1:implications for diabetic nephropathy[J].Endocrinology,2004,145(12):5646-5655.

共引文献6

同被引文献5

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部